NCG Clinical Trial Network (BIRAC)

NCG Clinical Trial Network

Clinical Trial Network

In November 2020, a clinical trial network in oncology was established under the National Cancer Grid with the grant from Biotechnology Industry Research Assistance Council, (BIRAC).

The purpose of this clinical trial network is to strengthen the clinical trial capacity across member centres to promote multi-centric high-quality trials. The network will provide a uniform platform to support innovation and development of biosimilars. The network has 11 centres with Tata Memorial Centre being the coordinating centre.


To establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative research in the field of drug and device development


  • A. Capacity building across all the sites of Network
  • B. Patient registry between the site network.
  • C. To make the site ready for clinical trial conduct.

Collaboration Details

NCG and BIRAC CTN Network

# Name of Institute City PI details
1 Tata Memorial Hospital Mumbai, Maharashtra Dr. R. A. Badwe
2 Advanced Center for Treatment Research and Education in Cancer (ACTREC) Navi Mumbai, Maharashtra Dr. Jayant SastriGoda
3 Dr. Bhubaneswar Borooah Cancer Institute Guwahati, Assam Dr. Ashok Kumar Das
4 Homi Bhabha Cancer Hospital Varanasi, Uttar Pradesh Dr. Satyajit Pradhan
5 Cancer Institute WIA Chennai, Tamil Nadu Dr. G. Selvaluxmy
6 Malabar Cancer Centre Thalassery, Kerala Dr. Satheesan B.
7 Max Super Specialty Hospital Saket, New Delhi Dr. Ramandeep Arora
8 North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) Shillong, Meghalaya Dr. Caleb Harris
9 Regional Cancer Centre Thiruvananthapuram, Kerala Dr. Beela Sarah Mathew
10 Christian Medical College Vellore, Tamil Nadu Dr. Vikram Mathews
11 Cachar Cancer Hospital and Research Center (CCHRC) Silchar, Assam Dr. Ravi Kannan

Salient Points:

  1. Uniform common network SOPs for clinical trial conduct.
  2. Trained manpower: The network has trained its manpower consisting of Project Manager (PM), Clinical Research Coordinator (CRC), Research Nurse, Research Pharmacist, Research Biostatistician, etc. in Good Clinical Practice (GCP), New Drug Clinical Trial rules 2019 (NDCT-2019), Indian Council of Medical Research (ICMR) guidelines, stakeholder responsibilities, monitoring, auditing, inspections and related clinical research topics.
  3. All the centres in the network have either a well-established clinical research pharmacy or a dedicated space for clinical research drugs in the existing respective institutional pharmacy.
  4. All the centres have a secured and well-equipped data storage facilities.
  5. The network member centres have developed and established a common cancer registry for disease areas: Breast, Colorectal, Lung, Gall Bladder, Lymphoma and Chronic MyloidLeukemia (CML). The registry captures following information: Demographics, History, Examination, Histopathology, Treatment Plan, Toxicity and Follow-up.

Education & Training - Research

Contact Us

In case a particular sponsor is interested to conduct a clinical trial, the sponsor may drop an email to:

Tata Memorial Hospital
CRS, 3 Floor, Main Building, Dr. E Borges Road, Parel, Mumbai 400 012 India

Hospital Number:
+91-22-24177000, Extn: 4274

For Patient Queries: